10-hydroxycamptothecin has been researched along with crizotinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Guo, L; Li, X; Liu, Z; Teng, Y; Xie, W; Xu, Y; Yu, P; Zhao, L | 1 |
1 other study(ies) available for 10-hydroxycamptothecin and crizotinib
| Article | Year |
|---|---|
Development of 10-Hydroxycamptothecin-crizotinib conjugate based on the synergistic effect on lung cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Crizotinib; ErbB Receptors; Humans; Lung Neoplasms | 2023 |